All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
XBI total return snapshot: XBI returned +86.53% over the past year and +27.55% YTD, with dividends reinvested. Since Feb. 6, 2006, XBI is up +901.50% in nominal total return, or +11.97%/yr, and is currently −10.11% below its total-return high on Feb. 8, 2021.
Data ending Fri Jun. 26, 2026
| Mon 2006-02-06💬 to Fri 2026-06-26 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| XBI × |
+27.55%
2026-06-26 |
+86.53%
2026-06-26 |
||||
| SPDR S&P Biotech ETF Exchange-Traded Fund | ||||||
| Mon 2006-02-06💬 to Fri 2026-06-26 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| XBI × |
+901.50%
+11.97%/yr |
+12.37%/yr
(R2=0.852) |
||||
| SPDR S&P Biotech ETF Exchange-Traded Fund | ||||||
| Mon 2006-02-06💬 to Fri 2026-06-26 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| XBI × |
$10,000.00
2006-02-06 |
$100,150.18
2026-06-26 |
||||
| SPDR S&P Biotech ETF Exchange-Traded Fund | ||||||
| Year | XBI |
|---|---|
| 2026 (YTD) | +27.55% |
| 2025 | +35.89% |
| 2024 | +1.01% |
| 2023 | +7.60% |
| 2022 | −25.87% |
| 2021 | −20.45% |
| 2020 | +48.33% |
| 2019 | +32.56% |
| 2018 | −15.28% |
| 2017 | +43.77% |
| 2016 | −15.45% |
| 2015 | +13.58% |
| 2014 | +44.97% |
| 2013 | +48.39% |
| 2012 | +32.69% |
| 2011 | +5.26% |
| 2010 | +17.60% |
| 2009 | +0.35% |
| 2008 | −8.57% |
| 2007 | +29.03% |
| 2006 | −6.31% |
| Mon 2006-02-06💬 to Fri 2026-06-26 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| XBI × |
−10.11%
from 2021-02-08 peak |
−63.89%
2022-05-11 from 2021-02-08 peak |
||||
| SPDR S&P Biotech ETF Exchange-Traded Fund | ||||||
| Period ending Fri 2026-06-26 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| XBI × | +86.53% |
+69.36% +30.14%/yr |
+88.00% +23.42%/yr |
+12.75% +2.43%/yr |
+204.00% +11.76%/yr |
|
| SPDR S&P Biotech ETF Exchange-Traded Fund | ||||||
